Lobbyist Insight

Ohio · Sep-Dec25

HB 388

Regards state employee reimbursement for GLP-1 drug costs

34 registered positions on this bill.

Lobbyist or firmFor clientPositionSession
American Diabetes AssociationMay-Aug26
Department of Administrative ServicesSep-Dec25
Allie ButchelloDepartment of Administrative ServicesSep-Dec25
Kathleen MaddenDepartment of Administrative ServicesSep-Dec25
Eli Lilly & CompanyMay-Aug25
David L CelonaEli Lilly & CompanyMay-Aug25
Edward SagebielEli Lilly & CompanyMay-Aug25
Hims, Inc.Sep-Dec25
John McClellandHims, Inc.Sep-Dec25
Industrial Commission of OhioSep-Dec25
James BurkartIndustrial Commission of OhioSep-Dec25
Julian HayslettIndustrial Commission of OhioSep-Dec25
Trent ChamplinIndustrial Commission of OhioSep-Dec25
Novo NordiskMay-Aug25
Jeffrey T DeLeoneNovo NordiskMay-Aug25
Matthew ForneyNovo NordiskMay-Aug25
Shawn NelsonNovo NordiskMay-Aug25
Office of the Ohio Public DefenderMay-Aug25
Elizabeth MillerOffice of the Ohio Public DefenderMay-Aug25
Zachary MillerOffice of the Ohio Public DefenderMay-Aug25
Ohio Chamber of CommerceMay-Aug25
Molly MottramOhio Chamber of CommerceMay-Aug25
Rick CarfagnaOhio Chamber of CommerceMay-Aug25
Matthew M DotsonOhio Education AssociationSep-Dec25
Ohio Life Sciences FoundationJan-Apr26
Willa BluestoneOhio Life Sciences FoundationJan-Apr26
Ohio Nurses AssociationSep-Dec25
Kelli HykesOhio Nurses AssociationSep-Dec25
Kevin L FutrykOhio Nurses AssociationSep-Dec25
Rachel EhresmanOhio Nurses AssociationSep-Dec25
Rick LucasOhio Nurses AssociationSep-Dec25
Ohio Restaurant & Hospitality AllianceMay-Aug25
Allison DeRobertsOhio Restaurant & Hospitality AllianceJan-Apr26
Tod BowenOhio Restaurant & Hospitality AllianceMay-Aug25

This state records which bills were lobbied but not which side was taken.